BeOne Medicines AG Inventory

BeOne Medicines AG (ONC) currently reports a inventory of $730M as of June 2026. That compares with $500M in the prior-year period — up 45.7% year over year. Use the charts on this page to explore BeOne Medicines AG's inventory history and peer comparisons.

BeOne Medicines AG's inventory increased from $500M to $730M — a 45.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BeOne Medicines AG reported $730M in inventory as of June 2026. That compares with $500M in the prior-year period — up 45.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $730M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BeOne Medicines AG, and consider following ONC for alerts when major investors trade the stock.

BeOne Medicines AG is classified in the Healthcare sector. On inventory, it currently shows $730M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONC with unrelated industries.